Puerarin alleviated oxidative stress and ferroptosis during renal fibrosis induced by ischemia/reperfusion injury via TLR4/Nox4 pathway in rats

Puerarin alleviated oxidative stress and ferroptosis during renal fibrosis induced by ischemia/reperfusion injury via TLR4/Nox4 pathway in rats

ABSTRACT Purpose: To investigate the role of puerarin on renal fibrosis and the underlying mechanism in renal ischemia and reperfusion (I/R) model. Methods: Rats were intraperitoneally injected with puerarin (50 or 100 mg/kg) per day for one week before renal I/R. The level of renal collagen depos...

Full description

Bibliographic Details
Main Authors:	Jun Jian, Dan Wang, Yufeng Xiong, Jingsong Wang, Qingyuan Zheng, Zhengyu Jiang, Jiacheng Zhong, Song Yang, Lei Wang
Format:	Article
Language:	English
Published:	Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2023-08-01
Series:	Acta Cirúrgica Brasileira
Subjects:	Chronic Kidney Disease Ferroptosis Reperfusion Injury Oxidative Stress
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502023000100219&tlng=en

Similar Items

Dexmedetomidine alleviates ferroptosis following hepatic ischemia-reperfusion injury by upregulating Nrf2/GPx4-dependent antioxidant responses
by: Yongjun Zhang, et al.
Published: (2023-12-01)

Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition
by: Weixiang Chen, et al.
Published: (2023-02-01)

Wedelolactone attenuates cerebral ischemia-reperfusion injury by blocking GPX4-mediated ferroptosis
by: Huyin Yang, et al.
Published: (2023-10-01)

Liproxstatin-1 Alleviated Ischemia/Reperfusion-Induced Acute Kidney Injury via Inhibiting Ferroptosis
by: Zhiyuan Shi, et al.
Published: (2024-01-01)

Current Status and Prospects of Research on Ischemia-Reperfusion Injury and Ferroptosis
by: Lin Hou, et al.
Published: (2022-08-01)

Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury
by: José Lillo-Moya, et al.
Published: (2021-04-01)

Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury
by: Yihang Pan, et al.
Published: (2022-11-01)

Ferroptosis: A Novel Therapeutic Target for Ischemia-Reperfusion Injury
by: Yunqing Chen, et al.
Published: (2021-08-01)

Nobiletin alleviates myocardial ischemia-reperfusion injury via ferroptosis in rats with type-2 diabetes mellitus
by: Qin Huang, et al.
Published: (2023-07-01)

Ozone pretreatment alleviates ischemiareperfusion injury-induced myocardial ferroptosis by activating the Nrf2/Slc7a11/Gpx4 axis
by: Shengyang Ding, et al.
Published: (2023-09-01)

Ferroptosis—A New Dawn in the Treatment of Organ Ischemia–Reperfusion Injury
by: Linxiang Zhou, et al.
Published: (2022-11-01)

Ischemia/reperfusion-activated ferroptosis in the early stage triggers excessive inflammation to aggregate lung injury in rats
by: Xiujie Liu, et al.
Published: (2023-06-01)

Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis
by: Fangyan Wang, et al.
Published: (2024-03-01)

Potential relationship between autophagy and ferroptosis in myocardial ischemia/reperfusion injury
by: Yu Yang, et al.
Published: (2023-11-01)

Deferasirox Targeting Ferroptosis Synergistically Ameliorates Myocardial Ischemia Reperfusion Injury in Conjunction With Cyclosporine A
by: Kosei Ishimaru, et al.
Published: (2024-01-01)

Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis
by: Zhenyu Fan, et al.
Published: (2021-04-01)

miR-135b-3p Promotes Cardiomyocyte Ferroptosis by Targeting GPX4 and Aggravates Myocardial Ischemia/Reperfusion Injury
by: Weixin Sun, et al.
Published: (2021-08-01)

Integrated Analysis of Ferroptosis and Immunity-Related Genes Associated with Intestinal Ischemia/Reperfusion Injury
by: Zhu L, et al.
Published: (2022-04-01)

Klf6 aggravates myocardial ischemia/reperfusion injury by activating Acsl4‐mediated ferroptosis
by: Ma‐Li Qiu, et al.
Published: (2023-10-01)

Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review
by: Cuihua Liu, et al.
Published: (2023-03-01)

Hydroxycitric Acid Alleviated Lung Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress and Ferroptosis through the Hif-1α Pathway
by: Zi-Long Lu, et al.
Published: (2023-12-01)

Procyanidins Alleviated Cerebral Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the Nrf2/HO-1 Signaling Pathway
by: Lei Chen, et al.
Published: (2023-04-01)

Hydroxysafflor Yellow A Alleviates Acute Myocardial Ischemia/Reperfusion Injury in Mice by Inhibiting Ferroptosis via the Activation of the HIF-1α/SLC7A11/GPX4 Signaling Pathway
by: Chaowen Ge, et al.
Published: (2023-07-01)

Analysis of the potential ferroptosis mechanism and multitemporal expression change of central ferroptosis-related genes in cardiac ischemia–reperfusion injury
by: Zuoxiang Wang, et al.
Published: (2022-08-01)

Histochrome Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting Ferroptosis-Induced Cardiomyocyte Death
by: Ji-Won Hwang, et al.
Published: (2021-10-01)

Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis
by: Xie J, et al.
Published: (2022-09-01)

Development and Validation of Robust Ferroptosis-Related Genes in Myocardial Ischemia-Reperfusion Injury
by: Xiuxian Wei, et al.
Published: (2023-08-01)

Mechanism of DYRK1a in myocardial ischemia–reperfusion injury by regulating ferroptosis of cardiomyocytes
by: Jing Wang, et al.
Published: (2023-12-01)

Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants
by: Simona Granata, et al.
Published: (2022-04-01)

A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis
by: Jing-yan Li, et al.
Published: (2021-12-01)

Knowledge mapping and emerging trends of ferroptosis in ischemia reperfusion injury research: A bibliometric analysis (2013–2022)
by: Nianzhe Sun, et al.
Published: (2023-10-01)

Cardiomyocyte Damage: Ferroptosis Relation to Ischemia-Reperfusion Injury and Future Treatment Options
by: Jolanta Laukaitiene, et al.
Published: (2023-08-01)

Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway
by: Shengqiang Li, et al.
Published: (2022-03-01)

Corrigendum: Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway
by: Shengqiang Li, et al.
Published: (2022-04-01)

Mitochondria-derived methylmalonic acid aggravates ischemia–reperfusion injury by activating reactive oxygen species-dependent ferroptosis
by: Junchen Guo, et al.
Published: (2024-01-01)

Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR
by: Wen-hui Tao, et al.
Published: (2022-06-01)

Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia/reperfusion injury by interacting with NAMPT
by: Jie Ju, et al.
Published: (2023-06-01)

Bioinformatics analysis of genes related to ferroptosis in hepatic ischemia-reperfusion injury
by: Shuo Sun, et al.
Published: (2022-12-01)

Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway
by: Yang T, et al.
Published: (2023-08-01)

Neuroprotective effect of Dl-3-n-butylphthalide against ischemia–reperfusion injury is mediated by ferroptosis regulation via the SLC7A11/GSH/GPX4 pathway and the attenuation of blood–brain barrier disruption
by: Shuangli Xu, et al.
Published: (2023-02-01)